NM_001331036.3:c.10G>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PP2PP5_ModerateBP4BS2

The NM_001331036.3(ELF2):​c.10G>A​(p.Ala4Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000226 in 1,461,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

ELF2
NM_001331036.3 missense

Scores

5
13

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 4.58

Publications

2 publications found
Variant links:
Genes affected
ELF2 (HGNC:3317): (E74 like ETS transcription factor 2) Enables DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of transcription, DNA-templated; positive regulation of transcription, DNA-templated; and regulation of transcription by RNA polymerase II. Located in cytosol and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 1 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Gene score misZ: 1.5919 (below the threshold of 3.09). Trascript score misZ: 2.8414 (below the threshold of 3.09).
PP5
Variant 4-139137692-C-T is Pathogenic according to our data. Variant chr4-139137692-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 431175.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.28851974). . Strength limited to SUPPORTING due to the PP5.
BS2
High AC in GnomAdExome4 at 33 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELF2NM_001331036.3 linkc.10G>A p.Ala4Thr missense_variant Exon 3 of 10 ENST00000686138.1 NP_001317965.1 Q15723-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELF2ENST00000686138.1 linkc.10G>A p.Ala4Thr missense_variant Exon 3 of 10 NM_001331036.3 ENSP00000510098.1 Q15723-5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000226
AC:
33
AN:
1461666
Hom.:
0
Cov.:
30
AF XY:
0.0000220
AC XY:
16
AN XY:
727136
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39660
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53314
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000297
AC:
33
AN:
1111964
Other (OTH)
AF:
0.00
AC:
0
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome Pathogenic:1
Aug 03, 2017
Otology & Neurotology- Genomics of vestibular disorders (CTS-495), Jose Antonio López Escámez, Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica (GENYO)
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:in vitro;research

Regulates the expression of ATXN2 and ELOVL5 genes, two Ataxia genes. -

not provided Uncertain:1
May 03, 2022
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.055
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.029
.;T
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Benign
0.0092
T
MetaRNN
Benign
0.29
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.7
L;L
PhyloP100
4.6
PROVEAN
Benign
-0.44
N;N
REVEL
Benign
0.12
Sift
Benign
0.066
T;T
Sift4G
Benign
0.16
T;T
Polyphen
1.0
D;.
Vest4
0.33
MutPred
0.20
Gain of relative solvent accessibility (P = 0.09);Gain of relative solvent accessibility (P = 0.09);
MVP
0.38
MPC
0.33
ClinPred
0.74
D
GERP RS
5.2
Varity_R
0.12
gMVP
0.32
Mutation Taster
=25/75
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747574524; hg19: chr4-140058846; COSMIC: COSV108100194; API